Marie-Nicole Theodoraki

Marie-Nicole Theodorakis is one of the leading experts in early cancer diagnosis using liquid biopsy, with a focus on head and neck cancer. She has driven clinical and translational research across academia and industry, contributing to over 60 publications and securing substantial third-party funding. As co-founder of Bioexotec, she aims to translate her long-standing research in cancer prevention into clinical practice. Her career reflects analytical precision, international collaboration, and leadership in patient safety and trial execution.